Sept 21 (Reuters) - Shares of VeriChip Corp (CHIP.O)tripled after the company said it had been granted an exclusivelicense to two patents, which will help it to developimplantable virus detection systems in humans. The patents, held by VeriChip partner Receptors LLC, relateto biosensors that can detect the H1N1 and other viruses, andbiological threats such as methicillin-resistant Staphylococcusaureus, VeriChip said in a statement. The technology will combine with VeriChip's implantableradio frequency identification devices to develop virus triagedetection systems. The triage system will provide multiple levels ofidentification -- the first will identify the agent as virus ornon-virus, the second level will classify the virus and alertthe user to the presence of pandemic threat viruses and thethird level will identify the precise pathogen, VeriChip saidin a white paper published May 7, 2009. Shares of VeriChip were up 186 percent at $3.28 Monday lateafternoon trade on Nasdaq. They had touched a year high of$3.43 earlier in the session.[url=http://www.reuters.com/article/rbssTechMediaTelecomNews/idUSBNG49295720090921?sp=true]source[/url]
What will they think of next! I guess if we are "buying," they will "sell." It is totally unclear to me as to how this is going to "help" anyone - it is the age old problem of us feeling the need to "know," like Eve in the garden of Eden. Many will buy into this thinking that knowing where the virus is will save them - but it will not. Only the Lord saves. We can not save ourselves.